metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Vitamin A toxicity in a physical culturist patient: A case report and review of ...
Journal Information
Vol. 5. Issue 4.
Pages 293-295 (October - December 2006)
Share
Share
Download PDF
More article options
Visits
4370
Vol. 5. Issue 4.
Pages 293-295 (October - December 2006)
Open Access
Vitamin A toxicity in a physical culturist patient: A case report and review of the literature
Visits
4370
Gustavo Castaño1,2,
Corresponding author
castano@intramed.net

Address for correspondence:
, Cristina Etchart3, Silvia Sookoian1,4
1 Department of Internal Medicine, Hospital “J.M. Penna”, Buenos Aires, Argentina
2 Consejo de Investigación, Government of the City of Buenos Aires
3 Pathology Division, Hospital “J.M. Penna“, Buenos Aires, Argentina
4 Instituto de Investigaciones Médicas “A. Lanari” Universidad de Buenos Aires CONICET
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Abstract

Excessive intake of vitamin A may produce acute or chronic toxicity. Vitamin A can be consumed in foods, fortified products and supplements. We present a case of a young physical culturist man who was referred to our Unit because of chronic liver disease of unknown origin. The patient had a history of increased vitamin A intake from natural source with the addition of high dose of vitamin A supplements with the purpose of improving his muscular development. Our patient showed chronic liver disease with severe fibrosis, signs of portal hypertension and marked hyperplasia of Ito cells. In conclusion, chronic vitamin A toxicity may produce severe liver damage and should be recognized in the differential diagnosis of chronic liver diseases.

Key words::
Hepatic stellate cells
Ito cells
portal hypertension
liver fibrosis
chronic hepatitis
Full Text

Abbreviations

ALT: alanine aminotransferases.

AST: aspartate aminotransferases.

HCV: hepatitis C virus.

HBV: hepatitis B virus.

HBc: hepatitis B core.

HBs: hepatitis B surface.

PAS: periodic acid Schiff’s.

Introduction

Higher organisms need Vitamin A to preserve normal cell growth and differentiation, the vision, immune response and reproduction.1 Nevertheless, excessive intake of vitamin A may produce acute or chronic toxicity. Vitamin A can be consumed in foods, fortified products and supplements. Consuming natural sources of this vitamin rarely results in chronic toxicity, with the exception of excessively high intake of carnivore liver on a continued basis.2,3 We present a case of chronic liver disease in a young physical culturist associated with increased vitamin A intake from natural source and supplements.

Case report

A 25 years old male patient was referred to our Liver Unit because of alanine (ALT) and aspartate aminotransferases (AST) elevations of more than 6 months length of unknown origin. He had no history of alcohol, illegal drugs or tobacco consumption, but he practiced physical culture and consumed a diet rich in meat and/or liver (more than 1,000 g per day). In order to improve his muscular development he used to supplement his food intake with high doses of vitamin A (220,000 IU/day) and consumed steroidal anabolic drugs. His physical examination disclosed a slightly enlarged spleen. The laboratory findings included increased levels of alkaline phosphatases (361 IU/L for a normal value up to 240 IU/L), AST (86 IU7L, normal value up to 40 IU/L), ALT (104 IU/L, normal value up to 40 IU/L) and y glutamyl transpeptidase (392 IU/L, normal value up to 50 IU/L). Viral markers for HCV and HIV were negative; auto-antibodies (anti nuclear, anti mitochondria, anti smooth muscle and anti liver-kidney-microsomes antibodies) were not found, and ferritin level was 406 ng/mL. The patient presented positive anti HBc and anti HBs antibodies. Ultrasound and Doppler duplex examination showed a normal liver structure, a portal vein with hepatopetal blood flow and an enlarged spleen.

Ultrasound assisted liver biopsy was performed using modified Menghini needle of 1.4 mm diameter (Hepafix, Braun, Germany). Liver sample was fixed in 10% formaldehyde, embedded in paraffin and stained with hematoxylin and eosin, Masson’s trichrome, silver impregnation for reticular fibers, Perls blue and PAS. Histological liver specimen showed seven portal tracts with slight lymphocytic infiltrates and bridging fibrosis. In the lobuli, manifest hyperplasia of Ito cells, mild steatosis and regenerative changes of hepatocytes were observed (Figures 1and2).

Figure 1.

Liver biopsy (Masson trichrome, 200X) showing advanced fibrosis and macrovacuolar steatosis.

(0.18MB).
Figure 2A.

Liver biopsy (a) HE, 400X;

(0.12MB).
Figure 2B.

b) PAS 1000X) highlighting hypertrophied Ito cells (IC) with vacuolated cytoplasm adjacent to hepatocytes (H), surrounding the endothelial cells (EC) and sinusoids (S).

(0.14MB).
Discussion

Vitamin A was identified for nearly a century as an essential dietary constituent.4-6 The term vitamin A refers to a group of compounds, including retinol, retinaldehyde, and retinoic acid. Retinol may be obtained directly from foods of animal origin, mainly from liver, fish liver oils, eggs and cream, or be formed in the body from metabolism of ¡-carotene.7 Vegetables contain β-carotene and other provitamin carotenoids, which are absorbed and then partially converted to retinol in the enterocytes. Retinol is esterified and incorporated into chylomicrons, which are released into the lymph and later into the systemic circulation. Hepatocytes take up retinol esters from chylomicron remnants, and after hydrolysis, retinol is removed to the hepatic stellate cells or is oxidized and excreted to the bile.2 Within the hepatic stellate cells, retinol may either be stored as esters of long-chain fatty acids in rich lipid droplets in the cytoplasm or transferred to the plasma bound to retinol binding protein and prealbumin to peripheral target tissues.8,9 Nuclear hormone receptors like the peroxisome proliferator-activated receptors (PPA-Rα, β, and γ) are possibly involved in the control of retinol esterification and storage (10)- Near 90% of vitamin A reserve is stored in the liver; other sites of major vitamin A storage include the eye and the lung.7

In addition to vitamin A storage, hepatic stellate cells control the extracellular matrix turnover in the space of Disse and contribute to the control of sinusoidal blood flow.11 Acute and chronic liver injury activates hepatic stellate cells to undergo transition into myofibroblast-like cells.12 Activated hepatic stellate cells play a key role in the fibrotic response to liver injury by means of an enhanced proliferation and increased synthesis of extracellular matrix proteins,13 and are target for several antifibrotic therapies.14-16

Excessive ingestion of vitamin A may produce acute or chronic toxicity. It has been known since XIX century that the ingestion of polar bear and seal liver may be toxic for humans, and in 1943 this fact was associated to vitamin A toxicity.17,18

Acute toxicity in children and adults may produce nausea, vomiting, diarrhea, fever and increased intracranial pressure. High dose vitamin A supplements can cause teratogenic effects, particularly if consumed during the first trimester of pregnancy.2

Chronic vitamin A toxicity can occur in adults who commonly consume doses of 100,000 IU per day for months or years, about 40 times the recommended dietary allowance,2,19 and may result in severe liver disease.20

Histological abnormalities include perisinusoidal fibrosis and liver cirrhosis, correlating the severity of perisinusoidal fibrosis with the dose of vitamin A.21 Hypertrophy of Ito cells is usually present and may be the clue in the diagnosis.22 Unfortunately, the mechanisms involved in liver fibrosis induced by vitamin A are not clear.23 Although vitamin A administration may prevent hepatic stellate cells transition and CCl4-induced injuries in rat livers,24 it was recently described in humans the relationship between the amount of liver fibrosis and the quantity of activated hepatic stellate cells in cases of vitamin A toxicity.21

Alcohol abuse, viral hepatitis, some medications and the presence of other liver diseases may accelerate this liver damage, which can be fatal. In a large series of forty one patients with chronic vitamin A liver toxicity, cirrhosis was present in seventeen.25 Cirrhotic and non-cirrhotic portal hypertension with ascites and hydrothorax may be also present.25-29 Nonetheless, with early diagnosis reversal of the abnormalities can be obtained.29

Our patient showed chronic liver disease with severe fibrosis, signs of portal hypertension and marked hyperplasia of Ito cells. This pathological condition was associated with a history of increased vitamin A intake from natural source and supplements, although additional toxicity produced by anabolic intake could not be ruled out. Patients consuming vitamin A supplements should be aware of the toxic effect of vitamin A overdose, and physicians should recognize this entity in the differential diagnosis of chronic liver diseases.

References
[1.]
Goodman D.S..
Vitamin A and Retinoids in Health and Disease..
N Engl J Med, 310 (19-4-1984), pp. 1023-1031
[2.]
Allen L.H., Haskell M..
Estimating the Potential for Vitamin A Toxicity in Women and Young Children..
J Nutr, 132 (2002), pp. 2907-2919
[3.]
Mahoney C P, Margolis M.T., Knauss T.A., Labbe R.F..
Chronic Vitamin A Intoxication in Infants Fed Chicken Liver..
Pediatrics, 65 (1980), pp. 893-897
[4.]
Hopkins F.G..
Feeding Experiments Illustrating the Importance of Accessory Factors in Normal Dietaries..
J Physiol, 44 (1912), pp. 425-460
[5.]
McCollum E.V..
Early Experiences With Vitamin A-a Retrospect..
[6.]
McCollum E.V..
The Paths to the Discovery of Vitamins A and D..
J Nutr, 91 (1967),
[7.]
Mactier H., Weaver L.T..
Vitamin A and Preterm Infants: What We Know, What We Don’t Know, and What We Need to Know..
Arch Dis Child Fetal Neonatal Ed, 90 (2005), pp. F103-F108
[8.]
Blomhoff R., Green M.H., Green J.B., Berg T., Norum K.R..
Vitamin A Metabolism: New Perspectives on Absorption, Transport, and Storage..
Physiol Rev, 71 (1991), pp. 951-990
[9.]
Norum K.R., Blomhoff R..
McCollum Award Lecture, 1992: Vitamin A Absorption, Transport, Cellular Uptake, and Storage..
Am J Clin Nutr, 56 (1992), pp. 735-744
[10.]
Hellemans K., Rombouts K., Quartier E., Dittie A.S., Knorr A., Michalik L., Rogiers V., et al.
PPARbeta Regulates Vitamin A Metabolism-Related Gene Expression in Hepatic Stellate Cells Undergoing Activation..
J Lipid Res, 44 (2003), pp. 280-295
[11.]
Geerts A..
History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells..
Semin Liver Dis, 21 (2001), pp. 311-336
[12.]
Marra F..
Hepatic Stellate Cells and the Regulation of Liver Inflammation..
J Hepatol, 31 (1999), pp. 1120-1130
[13.]
Friedman S.L..
Cytokines and Fibrogenesis..
Semin Liver Dis, 19 (1999), pp. 129-140
[14.]
Albanis E., Friedman S.L..
Antifibrotic Agents for Liver Disease..
Am J Transplant, 6 (2006), pp. 12-19
[15.]
Friedman S.L..
Mechanisms of Disease: Mechanisms of Hepatic Fibrosis and Therapeutic Implications..
Nat Clin Pract Gastroenterol Hepatol, 1 (2004), pp. 98-105
[16.]
Sookoian S., Fernandez M.A., Castano G..
Effects of Six Months Losartan Administration on Liver Fibrosis in Chronic Hepatitis C Patients: a Pilot Study..
World J Gastroenterol, 11 (28-12-2005), pp. 7560-7563
[17.]
Rodahl K., Moore T..
The Vitamin A Content and Toxicity of Bear and Seal Liver..
Biochem J, 37 (1943), pp. 166-168
[18.]
Rodahl K., Davies A.W..
Vitamin A in Seals..
Biochem J, 45 (1949), pp. 408-412
[19.]
Ross D.A..
Recommendations for Vitamin A Supplementation..
J Nutr, 132 (2002), pp. 2902-2906
[20.]
Russell R.M., Boyer J.L., Bagheri S.A., Hruban Z..
Hepatic Injury From Chronic Hypervitaminosis a Resulting in Portal Hypertension and Ascites..
N Engl J Med, 291 (29-8-1974), pp. 435-440
[21.]
Nollevaux M.C., Guiot Y., Horsmans Y., Leclercq I., Rahier J., Geubel A.P., Sempoux C..
Hypervitaminosis A-Induced Liver Fibrosis: Stellate Cell Activation and Daily Dose Consumption..
[22.]
Kistler H.J., Pluer S., Dickenmann W., Pirozynski W..
[Portal Hypertension Without Liver Cirrhosis in Chronic Vitamin A Intoxication]..
Schweiz Med Wochenschr, 107 (18-6-1977), pp. 825-832
[23.]
Hendriks H.F., Bosma A., Brouwer A..
Fat-Storing Cells: Hyper-and Hypovitaminosis A and the Relationships With Liver Fibrosis..
Semin Liver Dis, 13 (1993), pp. 72-80
[24.]
Noyan S., Cavusoglu I., Minbay F.Z..
The Effect of Vitamin A on CCl4-Induced Hepatic Injuries in Rats: a Histochemical, Immunohistochemical and Ultrastructural Study..
Acta Histochem, 107 (2006), pp. 421-434
[25.]
Geubel A.P., De Galocsy C., Alves N., Rahier J., Dive C..
Liver Damage Caused by Therapeutic Vitamin A Administration: Estimate of Dose-Related Toxicity in 41 Cases..
Gastroenterology, 100 (1991), pp. 1701-1709
[26.]
Miksad R., de Ledinghen V., McDougall C., Fiel I., Rosenberg H..
Hepatic Hydrothorax Associated With Vitamin a Toxicity..
J Clin Gastroenterol, 34 (2002), pp. 275-279
[27.]
Jacques E.A., Buschmann R.J., Layden T.J..
The Histopathologic Progression of Vitamin A-Induced Hepatic Injury..
Gastroenterology, 76 (1979), pp. 599-602
[28.]
Muenter M.D., Perry H.O., Ludwig J..
Chronic Vitamin A Intoxication in Adults. Hepatic, Neurologic and Dermatologic Complications..
Am J Med, 50 (1971), pp. 129-136
[29.]
Guarascio P., Portmann B., Visco G., Williams R..
Liver Damage With Reversible Portal Hypertension From Vitamin A Intoxication: Demonstration of Ito Cells..
J Clin Pathol, 36 (1983), pp. 769-771
Copyright © 2006. Fundación Clínica Médica Sur, A.C.
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos